Apolipoprotein (apo) E4 is a major risk factor for Alzheimer disease. Although the mechanisms remain to be determined, the detrimental effects of apoE4 in neurobiology must be based on its unique structural and biophysical properties. One such property is domain interaction mediated by a salt bridge between Arg-61 in the N-terminal domain and Glu-255 in the C-terminal domain of apoE4. This interaction, which does not occur in apoE3 or apoE2, causes apoE4 to bind preferentially to certain lipoprotein particles in vitro and in vivo. Here we used fluorescence resonance energy transfer (FRET) to determine whether apoE4 domain interaction occurs in living neuronal cells. Neuro-2a cells were transfected with constructs encoding apoE3 or apoE4 in which yellow fluorescent protein (YFP) was fused to the N terminus, and cyan fluorescent protein (CFP) was fused to the C terminus. To generate a FRET signal that can be detected by spectrum confocal microscopy, the labeled N and C termini must be in close proximity (<100 Å). FRET signals occurred in cells transfected with YFP-apoE4-CFP but not in those transfected with YFP-apoE3-CFP, suggesting that the N and C termini of apoE4 are in close proximity in living cells and that those of apoE3 are not. FRET signals did not occur in cells cotransfected with YFP-apoE4 and apoE4-CFP, suggesting that the FRET in YFP-apoE4-CFP-transfected cells was intramolecular. Mutation of Arg-61 to Thr or Glu-255 to Ala in apoE4, which disrupts domain interaction, abolished FRET in Neuro-2a cells, strongly suggesting that the FRET in YFP-apoE4-CFP cells was caused by domain interaction. ApoE4-producing cells secreted less phospholipid than apoE3-producing cells, but after disruption of domain interaction in apoE4, phospholipid secretion increased to the levels seen with apoE3, suggesting that domain interaction decreases the phospholipid-binding capacity of apoE4. Thus, apoE4 domain interaction occurs in living neuronal cells and may be a molecular basis for apoE4-related neurodegeneration.
Alzheimer's disease (AD) 1 is a neurodegenerative disorder characterized by progressive dementia (1, 2) . One isoform of human apolipoprotein (apo) E, apoE4, is a major risk factor for AD (3) (4) (5) (6) (7) (8) . ApoE4 is found in neurofibrillary tangles and amyloid plaques, which are two neuropathological hallmarks of AD (2, 3, 9 -13) . Although its pathogenic role in these lesions is still poorly understood, apoE4 has several adverse effects that might explain its association with AD. ApoE4 modulates the deposition and clearance of amyloid-␤ peptides and plaque formation (14 -20) , impairs the antioxidative defense system (21) , dysregulates neuronal signaling pathways (22) , disrupts cytoskeletal structure and function (23, 24) , alters the phosphorylation of tau and the formation of neurofibrillary tangles (25) (26) (27) (28) , and potentiates lysosomal leakage and apoptosis induced by amyloid-␤ peptides in neuronal cells (29) . The mechanisms of these effects are still largely unknown, and it is not known whether they result directly or indirectly from apoE activities or to what extent they contribute to the pathogenesis of AD-related dementia.
Because the structural and biophysical properties of a protein determine its function, the detrimental effects of apoE4 in neurobiology must reflect properties unique to apoE4. ApoE3 and apoE4 have identical amino acid sequences, except at position 112, where apoE4 has arginine and apoE3 has cysteine (30 -33) . This exception results in fundamental structural and biophysical differences (30 -34) . For example, apoE4 displays domain interaction mediated by a salt bridge between Arg-61 in the N terminus and Glu-255 in the C terminus, leading to a compact structure (35, 36) . Consequently, apoE4 binds preferentially to triglyceride-rich very low density lipoproteins (35, 36) . ApoE3, which lacks the domain interaction, is predicted to have a more open structure, and it binds preferentially to phospholipid-rich high density lipoproteins (35, 36) . ApoE4 domain interaction occurs on lipoprotein particles in vitro in human plasma (35, 36) and in vivo in Arg-61 knock-in mice (37) , in which domain interaction was introduced into mouse apoE by mutating Thr-61 to Arg.
Although it was initially believed that apoE was primarily synthesized by astrocytes in the brain but not by neurons (38) , numerous subsequent studies (39 -54) have demonstrated that central nervous system neurons also express apoE, albeit at lower levels than astrocytes, under diverse physiological and pathological conditions. Notably, transgenic mice expressing apoE4 specifically in central nervous system neurons are more susceptible to age-induced and excitotoxin-induced neurodegeneration (55) (56) (57) and behavioral deficits (55, 58) than transgenic mice with similar expression of apoE3. Domain interaction may contribute to the neurodegenerative effects of apoE4 in those transgenic mice (31, 34, 59, 60) ; however, domain interaction has not been demonstrated in living neuronal cells.
To explore this fundamental question, we used fluorescence resonance energy transfer (FRET) to analyze living neuronal cells expressing apoE3 or apoE4. FRET is the nonradiative transfer of photon energy from an excited fluorophore (donor) to another fluorophore (acceptor). The transfer occurs only when the donor and acceptor are in close proximity (Ͻ100 Å). Thus, this approach can be used to measure nanometer scale distances. FRET has been used to study domain reorganization induced by lipid association in human apoE3 (61, 62) . Recent advances, such as new fluorescent probes and new imaging methods, have made it possible to use this technique to detect protein-protein interactions and changes in protein conformation in living cells (63) (64) (65) (66) (67) (68) (69) . For example, cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) can be used to label two proteins to detect intermolecular interactions or to label two termini of a protein to detect intramolecular domain interaction in living cells by measuring FRET (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) .
In the current study, we used FRET to examine apoE4 domain interaction in living neuronal cells expressing apoE3 or apoE4 fused to fluorescent proteins (YFP-apoE3-CFP and YFPapoE4-CFP). Our results demonstrate that domain interaction of apoE4 occurs in living neuronal cells and might be a molecular basis for apoE4-related neurodegeneration.
EXPERIMENTAL PROCEDURES
Materials-Minimum essential medium, N2 medium supplements, and fetal bovine serum were purchased from Invitrogen. The ECL chemiluminescence detection kit for Western blots was from Amersham Biosciences. Monoclonal anti-FLAG (M2) was from Sigma. Horseradish peroxidase-coupled anti-goat IgG was from DAKO (Carpinteria, CA).
Preparation of cDNA Constructs Encoding ApoE3 or ApoE4 Fused with YFP and CFP-PCR products encoding wild-type or mutated (Arg-61 to Thr or Glu-255 to Ala) human apoE3 or apoE4 without a stop codon were subcloned into a pFLAG-CMV3 vector (Sigma) that contains an N-terminal FLAG tag and a signal peptide sequence. A PCR product encoding YFP without a stop codon was amplified from the pEYFP-N1 vector (Clontech) and subcloned into the pFLAG-CMV3-apoE3, pFLAG-CMV3-apoE4, pFLAG-CMV3-apoE4-Thr-61, or pFLAG-CMV3-apoE4-Ala-255 vector at the N terminus of apoE. Finally, a PCR product encoding CFP with a stop codon was amplified from the pECFP-C1 vector (Clontech) and subcloned into the pFLAG-CMV3-YFP-apoE3, pFLAG-CMV3-YFP-apoE4, pFLAG-CMV3-YFP-apoE4-Thr-61, or pFLAG-CMV3-YFP-apoE4-Ala-255 vector at the C terminus of apoE. cDNA constructs encoding YFP-apoE3-CFP, YFP-apoE4-CFP, YFPapoE4-Thr-61-CFP, or YFP-apoE4-Ala-255-CFP were generated. All DNA constructs were confirmed by sequence analysis.
Cell Cultures and Transfection-Mouse neuroblastoma Neuro-2a cells (American Type Culture Collection) were maintained at 37°C in minimum essential medium containing 10% fetal bovine serum. Neuro-2a cells were transiently transfected with the apoE cDNA constructs described above using LipofectAMINE 2000 reagent (Invitrogen) (27) .
Western Blotting-Neuro-2a cells were harvested 24 h after transfection with various apoE cDNA constructs and lysed in ice-cold lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate, and Roche complete protease inhibitors) for 30 min. After centrifugation at 13,000 rpm for 15 min in an Eppendorf centrifuge (Westbury, NY), apoE labeled with both YFP and CFP was detected in the supernatant by Western blotting with M2 monoclonal antibodies against the FLAG tag (Sigma) (75) .
Imaging FRET by Multiphoton Confocal Microscopy-Neuro-2a cells transiently transfected with the YFP-apoE3-CFP or YFP-apoE4-CFP cDNA construct were grown in serum-free minimum essential medium for 18 -20 h, illuminated with a Zeiss two-photon laser, and examined with a Zeiss confocal microscope. To visualize CFP fluorescence, transfected cells were excited at 458 nm, and images were acquired at 465-512 nm. FRET images were acquired at the emission wavelength of YFP (543-618 nm) when CFP was excited (66, 67, 76, 77) . Although YFP and CFP have broad absorption and emission peaks that partially overlap, the Meta Detector of the Zeiss multiphoton confocal system can deconvolve the contribution of each fluorochrome to each pixel by spectral analysis, using information obtained from the reference spectra (YFP or CFP alone). Thus, we were able to image YFP and CFP fluorescence simultaneously in neurons expressing YFP-apoE3-CFP or YFP-apoE4-CFP at similar levels for FRET analysis.
Quantifying FRET in Transfected Neuro-2a Cells-Transiently transfected Neuro-2a cells expressing YFP-apoE3-CFP or YFP-apoE4-CFP at similar levels were selected by fluorescence microscopy. YFP and CFP images of transfected cells were acquired with the Meta Detector, and their fluorescence intensities were analyzed with the mounted computer. The FRET signal was calculated as the ratio of YFP to CFP fluorescence intensity under CFP excitation (65-67, 78, 79) . For each YFP-apoE-CFP construct, the FRET signal was measured in at least 12 cells from different fields.
Detecting FRET by Photobleaching YFP Fluorescence in Transfected Cells-After the CFP images were acquired and their fluorescence intensities were calculated, a strong laser (514 nm, 100% power, eight 10-s cycles) was used to photobleach YFP fluorescence in cells expressing YFP-apoE3-CFP, YFP-apoE4-CFP, or both YFP-apoE4 and apoE4-CFP. CFP images were then acquired, and their fluorescence intensities were recalculated. An increase in CFP fluorescence intensity after photobleaching of YFP fluorescence indicates FRET (66, 73, 80) . For each experiment, more than six fields of the slides were photobleached.
Quantifying FRET in the Culture Medium-Neuro-2a cells stably expressing YFP-apoE3-CFP or YFP-apoE4-CFP and wild-type cells were grown in T175 flasks to 90% confluence and incubated for 24 h with serum-free minimum essential medium containing N2 supplement. The conditioned medium (20 ml/flask) was concentrated approximately 20-fold with Centriplus-YM-10 concentrators (Amicon, Bedford, MA), dialyzed against phosphate-buffered saline, illuminated at the CFP excitation wavelength (430 nm), and scanned for emission spectrum. The FRET signal was calculated as the ratio of emission at 525 nm (YFP) to that at 475 nm (CFP). Conditioned medium from cells expressing apoE3-CFP or apoE4-CFP was used to determine base-line fluorescence in the absence of FRET.
Determining the Lipid Content of ApoE-containing Lipoproteins in Culture Medium-Cells transiently or stably expressing apoE3, apoE4, YFP-apoE3-CFP, YFP-apoE4-CFP, or YFP-apoE4-Thr-61-CFP were incubated in T175 flasks containing serum-free minimum essential medium with N2 supplement (20 ml/flask) for 24 h. After concentration as described above, 100 l of conditioned medium was incubated overnight with 3 l of anti-apoE IgG (Calbiochem) at 4°C and then with 60 l of protein A-agarose beads (Bio-Rad) at 4°C for 4 h and centrifuged at 6000 ϫ g for 5 min to precipitate apoE-containing lipoprotein particles. To confirm complete precipitation of apoE, the supernatant was subjected to anti-apoE Western blotting. The concentrations of phospholipid, cholesterol, and triglyceride in the medium before and after immunoprecipitation were determined as described (81) . The amount of lipids bound with various forms of apoE was calculated by subtracting the value obtained after anti-apoE immunoprecipitation from that obtained before immunoprecipitation. The levels of apoE3, apoE4, YFPapoE3-CFP, YFP-apoE4-CFP, or YFP-apoE4-Thr-61-CFP in the conditioned medium were measured semiquantitatively by anti-apoE Western blotting (81) and used to normalize the lipids bound with various forms of apoE.
Statistical Analysis-Results are reported as mean Ϯ S.D. Differences were evaluated by Student's t test or analysis of variance.
RESULTS AND DISCUSSION
To determine whether apoE4 domain interaction occurs in living neuronal cells, we prepared cDNA constructs encoding YFP-apoE3-CFP or YFP-apoE4-CFP (Fig. 1A) . Control cDNA constructs encoding YFP-apoE3, apoE3-CFP, YFP-apoE4, or apoE4-CFP were also prepared. All of these fusion proteins have a FLAG tag at the N terminus. After transient transfection of mouse neuroblastoma Neuro-2a cells with these constructs, all of the singly and doubly labeled forms of apoE were detected at similar levels in cell lysates (Fig. 1A) and medium (data not shown) by Western blotting with monoclonal anti-FLAG.
Because the emission spectrum of CFP (460 -520 nm) overlaps with the excitation spectrum of YFP (480 -520 nm), spectrum confocal microscopy can be used to measure FRET in living cells (70, 71) . If CFP and YFP are in close proximity (Ͻ100 Å), part of the emission energy under CFP excitation is transferred from CFP to YFP, thereby increasing YFP emission and decreasing CFP emission. Thus, the occurrence of FRET in transfected Neuro-2a cells expressing double-labeled apoE in-dicates close proximity of the N and C termini, consistent with domain interaction in apoE4. The absence of FRET or a very weak FRET signal suggests that the two termini are farther apart, consistent with the lack of domain interaction in apoE3 (Fig. 1B) .
FRET Occurs Only in Neuro-2a Cells Expressing YFPapoE4-CFP-
We used three approaches to detect FRET in transfected Neuro-2a cells. First, we imaged YFP fluorescence under CFP excitation (66, 67, 76, 77) . A strong FRET signal was detected in Neuro-2a cells expressing YFP-apoE4-CFP (Fig. 2) , suggesting that the N and C termini of apoE4 are Ͻ100 Å apart, presumably because of domain interaction. However, very weak (or background) FRET (YFP) fluorescence was detected in cells expressing YFP-apoE3-CFP, suggesting that the two termini of apoE3 are separated by Ͼ100 Å, indicating a lack of domain interaction.
Second, we determined the ratio of FRET (YFP) to CFP fluorescence as a measurement of the FRET intensity in Neuro-2a cells expressing YFP-apoE3-CFP or YFP-apoE4-CFP (65-67, 78, 79) . When FRET occurs under excitation of CFP, YFP emission increases, and CFP emission decreases, reflecting energy transfer from CFP to YFP (Fig. 3A) . Therefore, the ratio of FRET (YFP) to CFP fluorescence can be used as a measure of FRET intensity. The higher the ratio, the stronger the FRET signal. The YFP-apoE4-CFP-transfected cells had a much higher ratio of FRET to CFP than the YFP-apoE3-CFPtransfected cells (Fig. 3B) , suggesting that FRET occurs in YFP-apoE4-CFP cells but not in YFP-apoE3-CFP cells.
Finally, we measured the change of the donor (CFP) fluorescence before and after laser photobleaching of the acceptor (YFP) fluorescence. If FRET occurs, this photobleaching will increase the donor (CFP) fluorescence because the energy cannot be transferred from CFP to YFP (66, 73, 80) . After photobleaching of YFP, CFP fluorescence increased significantly (ϳ25%) in YFP-apoE4-CFP cells (Fig. 4A) , indicating the occurrence of FRET, but decreased slightly in YFP-apoE3-CFP cells, indicating the absence of FRET (Fig. 4B) . The slight decrease in CFP fluorescence probably reflects photobleaching of CFP resulting from the partial overlap of the excitation spectra of YFP and CFP (73, 80) .
FRET in YFP-apoE4-CFP Cells Is Intramolecular-Next, we determined whether the FRET observed in YFP-apoE4-CFP cells was intramolecular, which could be caused by domain interaction, or intermolecular, which could be caused by dimerization or other protein-protein interactions. Neuro-2a cells were cotransfected with YFP-apoE4 and apoE4-CFP constructs. If intermolecular FRET occurred, we would detect FRET in cotransfected cells. After photobleaching of YFP fluorescence, CFP fluorescence did not increase in the cotransfected cells (Fig. 4C) , suggesting that intermolecular FRET does not occur in these cells. prepared two mutants, YFP-apoE4-Thr-61-CFP and YFPapoE4-Ala-255-CFP, in which domain interaction was disrupted and which have more open structures than apoE4 (Fig.  5A) . The ratios of FRET (YFP) to CFP fluorescence were significantly lower in Neuro-2a cells expressing the mutant proteins than in cells expressing YFP-apoE4-CFP at similar levels (Fig. 5B) , suggesting that the N and C termini of these two apoE4 mutants are separated by more than 100 Å. Interestingly, the ratios of YFP to CFP fluorescence in cells expressing the mutant proteins were similar to those of cells expressing YFP-apoE3-CFP. Thus, the two apoE4 mutants appear to be structurally similar to apoE3, as reported (35, 36) . These data strongly suggest that the FRET in YFP-apoE4-CFP cells is caused by apoE4 domain interaction.
FRET in YFP-apoE4-CFP Cells Is Caused by Domain Interaction-To

Fusion of Fluorescent Proteins with ApoE3 and ApoE4 Does Not Alter Their Lipid Binding
Properties-To determine whether the fusion of fluorescent proteins with apoE3 and apoE4 alters their lipid binding properties, which is one of the major functions of apoE, we measured lipid content of secreted apoE-containing lipoproteins. Both apoE4 and YFP-apoE4-CFP bound ϳ25% less phospholipid (pϽ 0.05) than apoE3 and YFP-apoE3-CFP (Fig.  6A) . Low levels of cholesterol and undetectable levels of triglyceride were found in the medium (data not shown). These results indicate that fusion of fluorescent proteins with apoE3 and apoE4 does not alter their lipid binding properties, suggesting that the presence of YFP and CFP does not significantly alter the folding or structural properties of apoE. These results also indicate that the cells secreted less phospholipid with apoE4 than with apoE3, suggesting decreased phospholipid-binding capacity of apoE4. Furthermore, a strong FRET signal was detected in the medium containing YFP-apoE4-CFP (Fig. 6B) , consistent with apoE4 domain interaction occurring in secreted phospholipidrich lipoprotein particles.
Domain Interaction Decreases Phospholipid-binding Capacity of ApoE4 -To determine whether domain interaction is responsible for the decreased phospholipid-binding capacity of apoE4, we compared the amount of phospholipid bound by YFP-apoE4-Thr-61-CFP, in which domain interaction had been disrupted (Fig. 5) , with that bound by YFP-apoE4-CFP or YFPapoE3-CFP. YFP-apoE4-Thr-61-CFP bound significantly more phospholipid than YFP-apoE4-CFP (p Ͻ 0.05). Importantly, YFP-apoE4-Thr-61-CFP and YFP-apoE3-CFP bound similar amounts of phospholipid (Fig. 6C) . Thus, disruption of domain interaction restores the phospholipid-binding capacity of apoE4 to a level similar to that of apoE3. These results strongly suggest that domain interaction decreases the phospholipidbinding capacity of apoE4, leading to secretion of less phospholipid from apoE4-producing cells than from apoE3-producing cells.
In summary, the current study demonstrates that apoE4 domain interaction occurs in living neuronal cells as determined by FRET and confirms that the FRET technique is a powerful tool for detecting intramolecular domain interaction of proteins in living cells. This study also reveals that domain interaction decreases the phospholipid-binding capacity of apoE4, leading to decreased secretion of phospholipid from apoE4-producing cells. Consistent with this finding, human apoE-producing primary astrocytes from apoE4 knock-in mice secrete less phospholipid than astrocytes from apoE3 knock-in mice (82) . Morphological and behavioral analyses of transgenic mice expressing apoE3 or apoE4 specifically in central nervous system neurons revealed significant age-dependent and excitotoxin-induced neurodegeneration and behavioral deficits in apoE4 but not apoE3 mice (55, 58) . Because the structural and biophysical properties of a protein determine its physiological or pathological functions, the intraneuronal apoE4 domain interaction observed in this study might be a molecular basis for apoE4-related neurodegeneration in apoE4 transgenic mice (31, 34, 59, 60) and probably also in humans. The development of drugs that can disrupt the intraneuronal apoE4 domain interaction should be beneficial for patients with AD and possibly other neurodegenerative diseases associated with apoE4. The cell-based FRET assay developed in the current study could be used to evaluate promising drug candidates in living neuronal cells. FIG. 6 . Domain interaction decreases phospholipid-binding capacity of apoE4. A, the concentration of phospholipid in cell culture medium containing various forms of secreted apoE was determined before and after immunoprecipitation with anti-apoE as described under "Experimental Procedures." The amount of phospholipid bound with apoE was calculated as the difference in the two values normalized by protein expression levels (n ϭ 3 for each bar; apoE3 versus apoE4 or YFP-apoE3-CFP versus YFP-apoE4-CFP, pϽ 0.05). B, the ratios of FRET to CFP in cell culture medium containing YFPapoE3-CFP or YFP-apoE4-CFP were measured under CFP excitation by fluorescence spectrometry (n ϭ 3 for each bar; pϽ 0.001). C, the amount of phospholipid bound with various forms of secreted apoE was determined as described in A (n ϭ 3 for each bar; YFP-apoE4-CFP versus YFPapoE3-CFP or YFP-apoE4-Thr-61-CFP, pϽ 0.05).
